Mariafausta Fischietti

6PUBLICATIONS
46CO-AUTHORS
Molecular targetsHaematological tumoursInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 21, 2025
Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies.

Elspeth M Beauchamp, Atul Jain, Matt Clutter

|Jun 28, 2023
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells.

Diana Saleiro, Ewa M Kosciuczuk, Mariafausta Fischietti

|Dec 27, 2022
Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint Inhibitors.

Sarah E Fenton, Markella Zannikou, Liliana Ilut

|Apr 02, 2022
Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms.

Diana Saleiro, Jeremy Q Wen, Ewa M Kosciuczuk

|Apr 13, 2021
Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma.

Mariafausta Fischietti, Frank Eckerdt, Gavin T Blyth

|Mar 04, 2021
OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia.

Bartholomew J Eisfelder, Caner Saygin, Joseph Wynne

Pageof 1